Bullock TN - Search Results

1

Formation and phenotypic characterization of CD49a, CD49b and CD103 expressing CD8 T cell populations in human metastatic melanoma.

Melssen MM, Olson W, Wages NA, Capaldo BJ, Mauldin IS, Mahmutovic A, Hutchison C, Melief CJM, Bullock TN, Engelhard VH, Slingluff CL Jr. Melssen MM, et al. Among authors: bullock tn. Oncoimmunology. 2018 Aug 6;7(10):e1490855. doi: 10.1080/2162402X.2018.1490855. eCollection 2018. Oncoimmunology. 2018. PMID: 30288359 Free PMC article.

2

The density of peptides displayed by dendritic cells affects immune responses to human tyrosinase and gp100 in HLA-A2 transgenic mice.

Bullock TN, Colella TA, Engelhard VH. Bullock TN, et al. J Immunol. 2000 Mar 1;164(5):2354-61. doi: 10.4049/jimmunol.164.5.2354. J Immunol. 2000. PMID: 10679070

3

Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy.

Colella TA, Bullock TN, Russell LB, Mullins DW, Overwijk WW, Luckey CJ, Pierce RA, Restifo NP, Engelhard VH. Colella TA, et al. Among authors: bullock tn. J Exp Med. 2000 Apr 3;191(7):1221-32. doi: 10.1084/jem.191.7.1221. J Exp Med. 2000. PMID: 10748239 Free PMC article.

4

Direct identification of human tumor-associated peptide antigens and a preclinical model to evaluate their use.

Engelhard VH, Bullock TN, Colella TA, Mullins DW. Engelhard VH, et al. Among authors: bullock tn. Cancer J. 2000 May;6 Suppl 3:S272-80. Cancer J. 2000. PMID: 10874498 Review.

5

Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic mice.

Mullins DW, Bullock TN, Colella TA, Robila VV, Engelhard VH. Mullins DW, et al. Among authors: bullock tn. J Immunol. 2001 Nov 1;167(9):4853-60. doi: 10.4049/jimmunol.167.9.4853. J Immunol. 2001. PMID: 11673489

6

Manipulation of avidity to improve effectiveness of adoptively transferred CD8(+) T cells for melanoma immunotherapy in human MHC class I-transgenic mice.

Bullock TN, Mullins DW, Colella TA, Engelhard VH. Bullock TN, et al. J Immunol. 2001 Nov 15;167(10):5824-31. doi: 10.4049/jimmunol.167.10.5824. J Immunol. 2001. PMID: 11698456

7

Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets.

Lippolis JD, White FM, Marto JA, Luckey CJ, Bullock TN, Shabanowitz J, Hunt DF, Engelhard VH. Lippolis JD, et al. Among authors: bullock tn. J Immunol. 2002 Nov 1;169(9):5089-97. doi: 10.4049/jimmunol.169.9.5089. J Immunol. 2002. PMID: 12391225

8

Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy.

Engelhard VH, Bullock TN, Colella TA, Sheasley SL, Mullins DW. Engelhard VH, et al. Among authors: bullock tn. Immunol Rev. 2002 Oct;188:136-46. doi: 10.1034/j.1600-065x.2002.18812.x. Immunol Rev. 2002. PMID: 12445287 Review.

9

Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells.

Bullock TN, Mullins DW, Engelhard VH. Bullock TN, et al. J Immunol. 2003 Feb 15;170(4):1822-9. doi: 10.4049/jimmunol.170.4.1822. J Immunol. 2003. PMID: 12574347

10

Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control.

Mullins DW, Sheasley SL, Ream RM, Bullock TN, Fu YX, Engelhard VH. Mullins DW, et al. Among authors: bullock tn. J Exp Med. 2003 Oct 6;198(7):1023-34. doi: 10.1084/jem.20021348. J Exp Med. 2003. PMID: 14530375 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters